English

Rosetta Genomics Ltd.

EDGAR

ROSG Foreign issuer report (6-K) · filed 2018-05-18

243 filing records in this dataset, filed from 2009-01-13 to 2018-05-18. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

870 thousand USD

2017 Q2 · USD

Exact inputs and evidence

Revenue: 870000 USD Source

Operating margin

-157.59%

2017 Q2 · %

Exact inputs and evidence

Operating Income: -1371000 USD Source
Revenue: 870000 USD Source

Cash and cash equivalents: 1.33 million USD 2017-06-30 Source
Exact value

1325000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 2.59 million shares 2017-06-30 Source
Exact value

2588086 shares

Reported share-count change

-87.60% · -18.3 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

20865568 shares · 2016-06-30· Source
2588086 shares · 2017-06-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2018-05-18.

Financial data available through: 2016-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2016-12-31
Operating income: 8 of 11 periods available· newest 2016-12-31
Net income: 8 of 11 periods available· newest 2016-12-31
Operating cash flow: 8 of 11 periods available· newest 2016-12-31
Capital expenditure: 8 of 11 periods available· newest 2016-12-31
Total assets: 7 of 11 periods available· newest 2016-12-31
Total liabilities: 2 of 11 periods available· newest 2016-12-31
Current assets: 7 of 11 periods available· newest 2016-12-31
Current liabilities: 7 of 11 periods available· newest 2016-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2016-12-31
long term debt: No compatible figures in this window
Shares outstanding: 7 of 11 periods available· newest 2016-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-29.1%

Prior period

USD 2.88 million

2015-01-01 – 2015-12-31
Current period

USD 2.04 million

2016-01-01 – 2016-12-31

Exact inputs and evidence

2039000 − 2875000 = -836000 USD

2875000 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
2039000 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Rosetta Genomics Ltd. · 2016-12-31 Rosetta Genomics Ltd. (edgar:1362959) Year-over-year change in Revenue: -836000 USD Concept: fundies:Revenue Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 2039000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420417051919/rosg-20161231.xml#124282 Filing: 000114420417051919 Input fundies:Revenue: 2875000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420417051919/rosg-20161231.xml#124424 Filing: 000114420417051919
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 1.11 million

Prior period

−USD 17.35 million

2015-01-01 – 2015-12-31
Current period

−USD 16.23 million

2016-01-01 – 2016-12-31

Exact inputs and evidence

-16233000 − -17345000 = 1112000 USD

-17345000 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
-16233000 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Rosetta Genomics Ltd. · 2016-12-31 Rosetta Genomics Ltd. (edgar:1362959) Year-over-year change in Net income: 1112000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -16233000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420417051919/rosg-20161231.xml#131318 Filing: 000114420417051919 Input fundies:NetIncome: -17345000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420417051919/rosg-20161231.xml#131458 Filing: 000114420417051919
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 26.66 million

Prior period

−USD 16.29 million

2015-01-01 – 2015-12-31
Current period

USD 10.37 million

2016-01-01 – 2016-12-31

Exact inputs and evidence

10367000 − -16294000 = 26661000 USD

-16294000 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
10367000 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Rosetta Genomics Ltd. · 2016-12-31 Rosetta Genomics Ltd. (edgar:1362959) Year-over-year change in Operating cash flow: 26661000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 10367000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420417051919/rosg-20161231.xml#1065737 Filing: 000114420417051919 Input fundies:OperatingCashFlow: -16294000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420417051919/rosg-20161231.xml#1394789 Filing: 000114420417051919
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-6.8%

Prior period

USD 117,000

2015-01-01 – 2015-12-31
Current period

USD 109,000

2016-01-01 – 2016-12-31

Exact inputs and evidence

109000 − 117000 = -8000 USD

117000 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
109000 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Rosetta Genomics Ltd. · 2016-12-31 Rosetta Genomics Ltd. (edgar:1362959) Year-over-year change in Capital expenditure: -8000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 109000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420417051919/rosg-20161231.xml#172020 Filing: 000114420417051919 Input fundies:CapitalExpenditure: 117000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420417051919/rosg-20161231.xml#172216 Filing: 000114420417051919
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2016 2016-01-01 – 2016-12-31

Revenue USD 2.04 million 100% of revenue
Cost of revenue USD 1.54 million 76% of revenue
Operating expenses USD 13.13 million 644% of revenue
Operating income −USD 12.64 million −620% of revenue
Tax, interest and other Derived USD 3.6 million 176% of revenue
Net income −USD 16.23 million −796% of revenue

Cash

Operating cash flow USD 10.37 million 508% of revenue
Capital expenditure USD 109,000 5.3% of revenue
Free cash flow Derived USD 10.26 million 503% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2009 Net income was higher than operating income, so the split is not drawn.
2010 Operating loss: operating costs were 5,087% of revenue.
2011 Operating loss: operating costs were 8,621% of revenue.
2012 Operating loss: operating costs were 4,213% of revenue.
2013 Operating loss: operating costs were 3,396% of revenue.
2014 Operating loss: operating costs were 1,174% of revenue.
2015 Operating loss: operating costs were 550% of revenue.
2016 Operating loss: operating costs were 720% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2009 2009-01-01 – 2009-12-31	150000	-14647000 Derived	14797000	-1708000 Derived	16505000	-11970000 Derived	Source 2009-01-01 – 2009-12-31: 150000 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: 14797000 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: 16505000 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -11771000 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 199000 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	279000	14194000 Derived	-13915000	1227000 Derived	-15142000	-14146000 Derived	Source 2010-01-01 – 2010-12-31: 279000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -13915000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -15142000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -13721000 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 425000 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	103000	8880000 Derived	-8777000	53000 Derived	-8830000	-11272000 Derived	Source 2011-01-01 – 2011-12-31: 103000 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -8777000 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -8830000 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -11261000 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 11000 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	201000	8468000 Derived	-8267000	2190000 Derived	-10457000	-8907000 Derived	Source 2012-01-01 – 2012-12-31: 201000 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -8267000 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -10457000 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -8637000 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 270000 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	405000	13752000 Derived	-13347000	-450000 Derived	-12897000	-11234000 Derived	Source 2013-01-01 – 2013-12-31: 405000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -13347000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -12897000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -10608000 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 626000 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	1327000	15579000 Derived	-14252000	274000 Derived	-14526000	-13849000 Derived	Source 2014-01-01 – 2014-12-31: 1327000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -14252000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -14526000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -13602000 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 247000 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	2875000	15819000 Derived	-12944000	4401000 Derived	-17345000	-16411000 Derived	Source 2015-01-01 – 2015-12-31: 2875000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -12944000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -17345000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -16294000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 117000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	2039000	14674000 Derived	-12635000	3598000 Derived	-16233000	10258000 Derived	Source 2016-01-01 – 2016-12-31: 2039000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -12635000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -16233000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: 10367000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 109000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 2M 2016

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Revenue	150000	Revenue: 150000 Open source
20102010-12-31	Revenue	279000	Revenue: 279000 Open source
20112011-12-31	Revenue	103000	Revenue: 103000 Open source
20122012-12-31	Revenue	201000	Revenue: 201000 Open source
20132013-12-31	Revenue	405000	Revenue: 405000 Open source
20142014-12-31	Revenue	1327000	Revenue: 1327000 Open source
20152015-12-31	Revenue	2875000	Revenue: 2875000 Open source
20162016-12-31	Revenue	2039000	Revenue: 2039000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-29.1% 2016

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Year over year	No prior comparable period	Revenue: 150000 Open source
20102010-12-31	Year over year	86%	Revenue: 279000 Open source Revenue: 150000 Open source
20112011-12-31	Year over year	-63.1%	Revenue: 103000 Open source Revenue: 279000 Open source
20122012-12-31	Year over year	95.1%	Revenue: 201000 Open source Revenue: 103000 Open source
20132013-12-31	Year over year	101.5%	Revenue: 405000 Open source Revenue: 201000 Open source
20142014-12-31	Year over year	227.7%	Revenue: 1327000 Open source Revenue: 405000 Open source
20152015-12-31	Year over year	116.7%	Revenue: 2875000 Open source Revenue: 1327000 Open source
20162016-12-31	Year over year	-29.1%	Revenue: 2039000 Open source Revenue: 2875000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -619.7% 2016

Net margin -796.1% 2016

Free cash flow margin 503.1% 2016

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Operating margin	9,864.7%	Operating Income: 14797000 Open source Revenue: 150000 Open source
20102010-12-31	Operating margin	-4,987.5%	Operating Income: -13915000 Open source Revenue: 279000 Open source
20112011-12-31	Operating margin	-8,521.4%	Operating Income: -8777000 Open source Revenue: 103000 Open source
20122012-12-31	Operating margin	-4,112.9%	Operating Income: -8267000 Open source Revenue: 201000 Open source
20132013-12-31	Operating margin	-3,295.6%	Operating Income: -13347000 Open source Revenue: 405000 Open source
20142014-12-31	Operating margin	-1,074%	Operating Income: -14252000 Open source Revenue: 1327000 Open source
20152015-12-31	Operating margin	-450.2%	Operating Income: -12944000 Open source Revenue: 2875000 Open source
20162016-12-31	Operating margin	-619.7%	Operating Income: -12635000 Open source Revenue: 2039000 Open source
20092009-12-31	Net margin	11,003.3%	Net Income: 16505000 Open source Revenue: 150000 Open source
20102010-12-31	Net margin	-5,427.2%	Net Income: -15142000 Open source Revenue: 279000 Open source
20112011-12-31	Net margin	-8,572.8%	Net Income: -8830000 Open source Revenue: 103000 Open source
20122012-12-31	Net margin	-5,202.5%	Net Income: -10457000 Open source Revenue: 201000 Open source
20132013-12-31	Net margin	-3,184.4%	Net Income: -12897000 Open source Revenue: 405000 Open source
20142014-12-31	Net margin	-1,094.6%	Net Income: -14526000 Open source Revenue: 1327000 Open source
20152015-12-31	Net margin	-603.3%	Net Income: -17345000 Open source Revenue: 2875000 Open source
20162016-12-31	Net margin	-796.1%	Net Income: -16233000 Open source Revenue: 2039000 Open source
20092009-12-31	Free cash flow margin	-7,980%	Revenue: 150000 Open source Operating Cash Flow: -11771000 Open source Capital Expenditure: 199000 Open source
20102010-12-31	Free cash flow margin	-5,070.3%	Revenue: 279000 Open source Operating Cash Flow: -13721000 Open source Capital Expenditure: 425000 Open source
20112011-12-31	Free cash flow margin	-10,943.7%	Revenue: 103000 Open source Operating Cash Flow: -11261000 Open source Capital Expenditure: 11000 Open source
20122012-12-31	Free cash flow margin	-4,431.3%	Revenue: 201000 Open source Operating Cash Flow: -8637000 Open source Capital Expenditure: 270000 Open source
20132013-12-31	Free cash flow margin	-2,773.8%	Revenue: 405000 Open source Operating Cash Flow: -10608000 Open source Capital Expenditure: 626000 Open source
20142014-12-31	Free cash flow margin	-1,043.6%	Revenue: 1327000 Open source Operating Cash Flow: -13602000 Open source Capital Expenditure: 247000 Open source
20152015-12-31	Free cash flow margin	-570.8%	Revenue: 2875000 Open source Operating Cash Flow: -16294000 Open source Capital Expenditure: 117000 Open source
20162016-12-31	Free cash flow margin	503.1%	Revenue: 2039000 Open source Operating Cash Flow: 10367000 Open source Capital Expenditure: 109000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 10.4M 2016

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Operating cash flow	-11771000	Operating Cash Flow: -11771000 Open source
20102010-12-31	Operating cash flow	-13721000	Operating Cash Flow: -13721000 Open source
20112011-12-31	Operating cash flow	-11261000	Operating Cash Flow: -11261000 Open source
20122012-12-31	Operating cash flow	-8637000	Operating Cash Flow: -8637000 Open source
20132013-12-31	Operating cash flow	-10608000	Operating Cash Flow: -10608000 Open source
20142014-12-31	Operating cash flow	-13602000	Operating Cash Flow: -13602000 Open source
20152015-12-31	Operating cash flow	-16294000	Operating Cash Flow: -16294000 Open source
20162016-12-31	Operating cash flow	10367000	Operating Cash Flow: 10367000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 10.3M 2016

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Free cash flow	-11970000	Operating Cash Flow: -11771000 Open source Capital Expenditure: 199000 Open source
20102010-12-31	Free cash flow	-14146000	Operating Cash Flow: -13721000 Open source Capital Expenditure: 425000 Open source
20112011-12-31	Free cash flow	-11272000	Operating Cash Flow: -11261000 Open source Capital Expenditure: 11000 Open source
20122012-12-31	Free cash flow	-8907000	Operating Cash Flow: -8637000 Open source Capital Expenditure: 270000 Open source
20132013-12-31	Free cash flow	-11234000	Operating Cash Flow: -10608000 Open source Capital Expenditure: 626000 Open source
20142014-12-31	Free cash flow	-13849000	Operating Cash Flow: -13602000 Open source Capital Expenditure: 247000 Open source
20152015-12-31	Free cash flow	-16411000	Operating Cash Flow: -16294000 Open source Capital Expenditure: 117000 Open source
20162016-12-31	Free cash flow	10258000	Operating Cash Flow: 10367000 Open source Capital Expenditure: 109000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

7.3% 2016

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2009-12-31	Liabilities / assets	Not reported	No source recorded
2010-12-31	Liabilities / assets	Not reported	Total Assets: 5293000 Open source
2011-12-31	Liabilities / assets	Not reported	Total Assets: 2044000 Open source
2012-12-31	Liabilities / assets	Not reported	Total Assets: 32530000 Open source
2013-12-31	Liabilities / assets	Not reported	Total Assets: 25880000 Open source
2014-12-31	Liabilities / assets	Not reported	Total Assets: 17278000 Open source
20152015-12-31	Liabilities / assets	2.9%	Total Liabilities: 656000 Open source Total Assets: 22423000 Open source
20162016-12-31	Liabilities / assets	7.3%	Total Liabilities: 874000 Open source Total Assets: 11961000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.5× 2016

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2009-12-31	Current assets / current liabilities	Not reported	No source recorded
20102010-12-31	Current assets / current liabilities	1.15×	Current Assets: 3839000 Open source Current Liabilities: 3331000 Open source
20112011-12-31	Current assets / current liabilities	0.65×	Current Assets: 1210000 Open source Current Liabilities: 1848000 Open source
20122012-12-31	Current assets / current liabilities	25.08×	Current Assets: 31753000 Open source Current Liabilities: 1266000 Open source
20132013-12-31	Current assets / current liabilities	12.9×	Current Assets: 24998000 Open source Current Liabilities: 1938000 Open source
20142014-12-31	Current assets / current liabilities	7.44×	Current Assets: 16452000 Open source Current Liabilities: 2211000 Open source
20152015-12-31	Current assets / current liabilities	6.91×	Current Assets: 19370000 Open source Current Liabilities: 2803000 Open source
20162016-12-31	Current assets / current liabilities	2.5×	Current Assets: 9513000 Open source Current Liabilities: 3804000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2009 2009-01-01 – 2009-12-31	USD 16.51 million Exact value Exact value: 16505000 USD 2009-01-01 – 2009-12-31: 16505000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Rosetta Genomics Ltd. · 2009-12-31 Rosetta Genomics Ltd. (edgar:1362959) Net Income: 16505000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: 16505000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420412066957/rosg-20111231.xml#48195 Filing: 000114420412066957 The citation records this snapshot. The page link may show a newer release later.	−USD 11.77 million Exact value Exact value: -11771000 USD 2009-01-01 – 2009-12-31: -11771000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Rosetta Genomics Ltd. · 2009-12-31 Rosetta Genomics Ltd. (edgar:1362959) Operating Cash Flow: -11771000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11771000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420412066957/rosg-20111231.xml#100784 Filing: 000114420412066957 The citation records this snapshot. The page link may show a newer release later.	USD 199,000 Exact value Exact value: 199000 USD 2009-01-01 – 2009-12-31: 199000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Rosetta Genomics Ltd. · 2009-12-31 Rosetta Genomics Ltd. (edgar:1362959) Capital Expenditure: 199000 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 199000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420412066957/rosg-20111231.xml#101324 Filing: 000114420412066957 The citation records this snapshot. The page link may show a newer release later.	−USD 11.97 million Calculation and evidence -11771000 − 199000 USD Exact free cash flow: -11970000 USD 2009-01-01 – 2009-12-31: -11771000 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 199000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Rosetta Genomics Ltd. · 2009-12-31 Rosetta Genomics Ltd. (edgar:1362959) Free cash flow: -11970000 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11771000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420412066957/rosg-20111231.xml#100784 Filing: 000114420412066957 Input fundies:CapitalExpenditure: 199000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420412066957/rosg-20111231.xml#101324 Filing: 000114420412066957 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 15.14 million Exact value Exact value: -15142000 USD 2010-01-01 – 2010-12-31: -15142000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Rosetta Genomics Ltd. · 2010-12-31 Rosetta Genomics Ltd. (edgar:1362959) Net Income: -15142000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15142000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420413016989/rosg-20121231.xml#261524 Filing: 000114420413016989 The citation records this snapshot. The page link may show a newer release later.	−USD 13.72 million Exact value Exact value: -13721000 USD 2010-01-01 – 2010-12-31: -13721000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Rosetta Genomics Ltd. · 2010-12-31 Rosetta Genomics Ltd. (edgar:1362959) Operating Cash Flow: -13721000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13721000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420413016989/rosg-20121231.xml#259789 Filing: 000114420413016989 The citation records this snapshot. The page link may show a newer release later.	USD 425,000 Exact value Exact value: 425000 USD 2010-01-01 – 2010-12-31: 425000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Rosetta Genomics Ltd. · 2010-12-31 Rosetta Genomics Ltd. (edgar:1362959) Capital Expenditure: 425000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 425000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420413016989/rosg-20121231.xml#309252 Filing: 000114420413016989 The citation records this snapshot. The page link may show a newer release later.	−USD 14.15 million Calculation and evidence -13721000 − 425000 USD Exact free cash flow: -14146000 USD 2010-01-01 – 2010-12-31: -13721000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 425000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Rosetta Genomics Ltd. · 2010-12-31 Rosetta Genomics Ltd. (edgar:1362959) Free cash flow: -14146000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13721000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420413016989/rosg-20121231.xml#259789 Filing: 000114420413016989 Input fundies:CapitalExpenditure: 425000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420413016989/rosg-20121231.xml#309252 Filing: 000114420413016989 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 8.83 million Exact value Exact value: -8830000 USD 2011-01-01 – 2011-12-31: -8830000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Rosetta Genomics Ltd. · 2011-12-31 Rosetta Genomics Ltd. (edgar:1362959) Net Income: -8830000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8830000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420414019402/rosg-20131231.xml#288289 Filing: 000114420414019402 The citation records this snapshot. The page link may show a newer release later.	−USD 11.26 million Exact value Exact value: -11261000 USD 2011-01-01 – 2011-12-31: -11261000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Rosetta Genomics Ltd. · 2011-12-31 Rosetta Genomics Ltd. (edgar:1362959) Operating Cash Flow: -11261000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11261000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420414019402/rosg-20131231.xml#286652 Filing: 000114420414019402 The citation records this snapshot. The page link may show a newer release later.	USD 11,000 Exact value Exact value: 11000 USD 2011-01-01 – 2011-12-31: 11000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Rosetta Genomics Ltd. · 2011-12-31 Rosetta Genomics Ltd. (edgar:1362959) Capital Expenditure: 11000 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420414019402/rosg-20131231.xml#342891 Filing: 000114420414019402 The citation records this snapshot. The page link may show a newer release later.	−USD 11.27 million Calculation and evidence -11261000 − 11000 USD Exact free cash flow: -11272000 USD 2011-01-01 – 2011-12-31: -11261000 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 11000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Rosetta Genomics Ltd. · 2011-12-31 Rosetta Genomics Ltd. (edgar:1362959) Free cash flow: -11272000 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11261000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420414019402/rosg-20131231.xml#286652 Filing: 000114420414019402 Input fundies:CapitalExpenditure: 11000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420414019402/rosg-20131231.xml#342891 Filing: 000114420414019402 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 10.46 million Exact value Exact value: -10457000 USD 2012-01-01 – 2012-12-31: -10457000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Rosetta Genomics Ltd. · 2012-12-31 Rosetta Genomics Ltd. (edgar:1362959) Net Income: -10457000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10457000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420415016317/rosg-20141231.xml#749133 Filing: 000114420415016317 The citation records this snapshot. The page link may show a newer release later.	−USD 8.64 million Exact value Exact value: -8637000 USD 2012-01-01 – 2012-12-31: -8637000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Rosetta Genomics Ltd. · 2012-12-31 Rosetta Genomics Ltd. (edgar:1362959) Operating Cash Flow: -8637000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8637000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420415016317/rosg-20141231.xml#761219 Filing: 000114420415016317 The citation records this snapshot. The page link may show a newer release later.	USD 270,000 Exact value Exact value: 270000 USD 2012-01-01 – 2012-12-31: 270000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Rosetta Genomics Ltd. · 2012-12-31 Rosetta Genomics Ltd. (edgar:1362959) Capital Expenditure: 270000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 270000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420415016317/rosg-20141231.xml#762963 Filing: 000114420415016317 The citation records this snapshot. The page link may show a newer release later.	−USD 8.91 million Calculation and evidence -8637000 − 270000 USD Exact free cash flow: -8907000 USD 2012-01-01 – 2012-12-31: -8637000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 270000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Rosetta Genomics Ltd. · 2012-12-31 Rosetta Genomics Ltd. (edgar:1362959) Free cash flow: -8907000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8637000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420415016317/rosg-20141231.xml#761219 Filing: 000114420415016317 Input fundies:CapitalExpenditure: 270000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420415016317/rosg-20141231.xml#762963 Filing: 000114420415016317 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 12.9 million Exact value Exact value: -12897000 USD 2013-01-01 – 2013-12-31: -12897000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Rosetta Genomics Ltd. · 2013-12-31 Rosetta Genomics Ltd. (edgar:1362959) Net Income: -12897000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12897000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420416138563/rosg-20151231.xml#125617 Filing: 000114420416138563 The citation records this snapshot. The page link may show a newer release later.	−USD 10.61 million Exact value Exact value: -10608000 USD 2013-01-01 – 2013-12-31: -10608000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Rosetta Genomics Ltd. · 2013-12-31 Rosetta Genomics Ltd. (edgar:1362959) Operating Cash Flow: -10608000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10608000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420416138563/rosg-20151231.xml#230880 Filing: 000114420416138563 The citation records this snapshot. The page link may show a newer release later.	USD 626,000 Exact value Exact value: 626000 USD 2013-01-01 – 2013-12-31: 626000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Rosetta Genomics Ltd. · 2013-12-31 Rosetta Genomics Ltd. (edgar:1362959) Capital Expenditure: 626000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 626000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420416138563/rosg-20151231.xml#231471 Filing: 000114420416138563 The citation records this snapshot. The page link may show a newer release later.	−USD 11.23 million Calculation and evidence -10608000 − 626000 USD Exact free cash flow: -11234000 USD 2013-01-01 – 2013-12-31: -10608000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 626000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Rosetta Genomics Ltd. · 2013-12-31 Rosetta Genomics Ltd. (edgar:1362959) Free cash flow: -11234000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10608000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420416138563/rosg-20151231.xml#230880 Filing: 000114420416138563 Input fundies:CapitalExpenditure: 626000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420416138563/rosg-20151231.xml#231471 Filing: 000114420416138563 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 14.53 million Exact value Exact value: -14526000 USD 2014-01-01 – 2014-12-31: -14526000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Rosetta Genomics Ltd. · 2014-12-31 Rosetta Genomics Ltd. (edgar:1362959) Net Income: -14526000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14526000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420417051919/rosg-20161231.xml#131598 Filing: 000114420417051919 The citation records this snapshot. The page link may show a newer release later.	−USD 13.6 million Exact value Exact value: -13602000 USD 2014-01-01 – 2014-12-31: -13602000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Rosetta Genomics Ltd. · 2014-12-31 Rosetta Genomics Ltd. (edgar:1362959) Operating Cash Flow: -13602000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13602000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420417051919/rosg-20161231.xml#1395028 Filing: 000114420417051919 The citation records this snapshot. The page link may show a newer release later.	USD 247,000 Exact value Exact value: 247000 USD 2014-01-01 – 2014-12-31: 247000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Rosetta Genomics Ltd. · 2014-12-31 Rosetta Genomics Ltd. (edgar:1362959) Capital Expenditure: 247000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 247000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420417051919/rosg-20161231.xml#172412 Filing: 000114420417051919 The citation records this snapshot. The page link may show a newer release later.	−USD 13.85 million Calculation and evidence -13602000 − 247000 USD Exact free cash flow: -13849000 USD 2014-01-01 – 2014-12-31: -13602000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 247000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Rosetta Genomics Ltd. · 2014-12-31 Rosetta Genomics Ltd. (edgar:1362959) Free cash flow: -13849000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13602000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420417051919/rosg-20161231.xml#1395028 Filing: 000114420417051919 Input fundies:CapitalExpenditure: 247000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420417051919/rosg-20161231.xml#172412 Filing: 000114420417051919 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 17.35 million Exact value Exact value: -17345000 USD 2015-01-01 – 2015-12-31: -17345000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Rosetta Genomics Ltd. · 2015-12-31 Rosetta Genomics Ltd. (edgar:1362959) Net Income: -17345000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17345000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420417051919/rosg-20161231.xml#131458 Filing: 000114420417051919 The citation records this snapshot. The page link may show a newer release later.	−USD 16.29 million Exact value Exact value: -16294000 USD 2015-01-01 – 2015-12-31: -16294000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Rosetta Genomics Ltd. · 2015-12-31 Rosetta Genomics Ltd. (edgar:1362959) Operating Cash Flow: -16294000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16294000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420417051919/rosg-20161231.xml#1394789 Filing: 000114420417051919 The citation records this snapshot. The page link may show a newer release later.	USD 117,000 Exact value Exact value: 117000 USD 2015-01-01 – 2015-12-31: 117000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Rosetta Genomics Ltd. · 2015-12-31 Rosetta Genomics Ltd. (edgar:1362959) Capital Expenditure: 117000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 117000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420417051919/rosg-20161231.xml#172216 Filing: 000114420417051919 The citation records this snapshot. The page link may show a newer release later.	−USD 16.41 million Calculation and evidence -16294000 − 117000 USD Exact free cash flow: -16411000 USD 2015-01-01 – 2015-12-31: -16294000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 117000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Rosetta Genomics Ltd. · 2015-12-31 Rosetta Genomics Ltd. (edgar:1362959) Free cash flow: -16411000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16294000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420417051919/rosg-20161231.xml#1394789 Filing: 000114420417051919 Input fundies:CapitalExpenditure: 117000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420417051919/rosg-20161231.xml#172216 Filing: 000114420417051919 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 16.23 million Exact value Exact value: -16233000 USD 2016-01-01 – 2016-12-31: -16233000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Rosetta Genomics Ltd. · 2016-12-31 Rosetta Genomics Ltd. (edgar:1362959) Net Income: -16233000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16233000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420417051919/rosg-20161231.xml#131318 Filing: 000114420417051919 The citation records this snapshot. The page link may show a newer release later.	USD 10.37 million Exact value Exact value: 10367000 USD 2016-01-01 – 2016-12-31: 10367000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Rosetta Genomics Ltd. · 2016-12-31 Rosetta Genomics Ltd. (edgar:1362959) Operating Cash Flow: 10367000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 10367000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420417051919/rosg-20161231.xml#1065737 Filing: 000114420417051919 The citation records this snapshot. The page link may show a newer release later.	USD 109,000 Exact value Exact value: 109000 USD 2016-01-01 – 2016-12-31: 109000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Rosetta Genomics Ltd. · 2016-12-31 Rosetta Genomics Ltd. (edgar:1362959) Capital Expenditure: 109000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 109000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420417051919/rosg-20161231.xml#172020 Filing: 000114420417051919 The citation records this snapshot. The page link may show a newer release later.	USD 10.26 million Calculation and evidence 10367000 − 109000 USD Exact free cash flow: 10258000 USD 2016-01-01 – 2016-12-31: 10367000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 109000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Rosetta Genomics Ltd. · 2016-12-31 Rosetta Genomics Ltd. (edgar:1362959) Free cash flow: 10258000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T21:46:59Z Snapshot: 2538d987fea03a50b3da871cd122d003c3a07143099cd71a1cee3b1ae5f36959 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1362959?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 10367000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420417051919/rosg-20161231.xml#1065737 Filing: 000114420417051919 Input fundies:CapitalExpenditure: 109000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1362959/000114420417051919/rosg-20161231.xml#172020 Filing: 000114420417051919 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

243 filings · 699 latest values · 699 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001362959, 1362959, ROSG, edgar:1362959, rosg

Also known as Rosetta Genomics Ltd.

Rosetta Genomics Ltd.

Latest quarter

Revenue

Operating margin

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2016 2016-01-01 – 2016-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation